A 24-week randomized trial of controlled-release physostigmine in patients with Alzheimer's disease
Thal, L. J., Ferguson, J. M., Mintzer, J., Raskin, A., Targum, S. D.Volume:
52
Language:
english
Journal:
Neurology
DOI:
10.1212/wnl.52.6.1146
Date:
April, 1999
File:
PDF, 2.00 MB
english, 1999